knowledge -WSS

knowledge

author：entertainment 2025-09-30 11:57:36 - browse：6815

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Trial using CRISPR to edit HIV out of cells disappoints

entertainment

WSS

Study: Black kids more likely to die after surgery than white kids

Gilead might be held responsible for not developing a drug

Scientists uncover potential path to treating deadly childhood tumor

The Readout: Gilead, Bernie Sanders, and other pharma news

BioAge raises $170M for combination therapy with Zepbound

What should King Charles tell the public about his cancer?

Wikipedia

knowledge

The need-to-know this morning

Novavax’s money is going in the wrong direction

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Wildfire smoke exposes gaps in outdoor worker protections

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Scientific mystery highlights the blind spots in genomics databases

At least 13 dead in Texas as scorching temps continue

To avoid data mishandling cases, universities eye AI and other tools

focus

PhRMA lawsuit over Medicare drug price negotiation tossed

Hundreds died while taking an arthritis drug, but nobody alerted patients

Gut bacteria may contribute to kidney autoimmunity, study finds

What should King Charles tell the public about his cancer?

Pancreatic cancer is often deadly, but new discoveries are raising hope

Four alarming medical procedures we’re glad history forgot

focus

leisure time

entertainment

hotspot